We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$13.5B
AUM Growth
-$537M
Cap. Flow
-$203M
Cap. Flow %
-1.51%
Top 10 Hldgs %
19.68%
Holding
385
New
13
Increased
113
Reduced
185
Closed
7

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$46.3M
2
QCOM icon
Qualcomm
QCOM
+$36.9M
3
ATKR icon
Atkore
ATKR
+$27.5M
4
WTRG icon
Essential Utilities
WTRG
+$26.1M
5
HALO icon
Halozyme
HALO
+$19.4M

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$43.2M
2
CPE
Callon Petroleum Company
CPE
+$35.4M
3
UMBF icon
UMB Financial
UMBF
+$31M
4
SLB icon
SLB Ltd
SLB
+$30.8M
5
JPM icon
JPMorgan Chase
JPM
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 24.52%
2 Financials 14.32%
3 Healthcare 14.05%
4 Industrials 13.81%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TT icon
326
Trane Technologies
TT
$92.4B
$454K ﹤0.01%
1,379
ARE icon
327
Alexandria Real Estate Equities
ARE
$9.12B
$436K ﹤0.01%
3,725
+50
+1% +$5.96K
AZN icon
328
AstraZeneca
AZN
$253B
$425K ﹤0.01%
2,728
+28
+1% +$4.21K
TRV icon
329
Travelers Companies
TRV
$78.6B
$417K ﹤0.01%
2,053
+25
+1% +$5.37K
OTIS icon
330
Otis Worldwide
OTIS
$26.4B
$404K ﹤0.01%
4,198
PLD icon
331
Prologis
PLD
$129B
$400K ﹤0.01%
3,558
NOW icon
332
ServiceNow
NOW
$151B
$397K ﹤0.01%
2,525
+30
+1% +$4.4K
VNQ icon
333
Vanguard Real Estate ETF
VNQ
$37B
$379K ﹤0.01%
4,522
QQQ icon
334
Invesco QQQ Trust
QQQ
$474B
$377K ﹤0.01%
787
-50
-6% -$22.5K
JEF icon
335
Jefferies Financial Group
JEF
$11.1B
$373K ﹤0.01%
7,500
WST icon
336
West Pharmaceutical
WST
$25.9B
$366K ﹤0.01%
1,110
-100
-8% -$35.3K
VEA icon
337
Vanguard FTSE Developed Markets ETF
VEA
$233B
$360K ﹤0.01%
7,281
-610
-8% -$30.4K
MDY icon
338
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.9B
$345K ﹤0.01%
645
HIG icon
339
Hartford Financial Services
HIG
$36.8B
$342K ﹤0.01%
3,400
-977
-22% -$98.1K
T icon
340
AT&T
T
$184B
$324K ﹤0.01%
16,939
-2,400
-12% -$41.7K
IJR icon
341
iShares Core S&P Small-Cap ETF
IJR
$106B
$324K ﹤0.01%
3,033
PAA icon
342
Plains All American Pipeline
PAA
$18.2B
$321K ﹤0.01%
18,000
IJH icon
343
iShares Core S&P Mid-Cap ETF
IJH
$122B
$321K ﹤0.01%
5,490
STZ icon
344
Constellation Brands
STZ
$21.1B
$312K ﹤0.01%
1,213
-287
-19% -$73.8K
DUK icon
345
Duke Energy
DUK
$91.8B
$299K ﹤0.01%
2,984
VGT icon
346
Vanguard Information Technology ETF
VGT
$146B
$297K ﹤0.01%
4,120
HSIC icon
347
Henry Schein
HSIC
$9.76B
$293K ﹤0.01%
4,567
-1,830
-29% -$129K
XRAY icon
348
Dentsply Sirona
XRAY
$1.99B
$289K ﹤0.01%
11,590
-7,450
-39% -$214K
LRGF icon
349
iShares US Equity Factor ETF
LRGF
$3.66B
$285K ﹤0.01%
5,120
GM icon
350
General Motors
GM
$75.2B
$283K ﹤0.01%
6,100
-200
-3% -$9.03K

Similar funds

Boston Trust Walden's Q2 2024 Portfolio in Review

As of Q2 2024, Boston Trust Walden held 385 positions worth $13.5B, down 3.8% from $14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2024 filing shows 13 new, 113 increased, 185 reduced and 7 closed positions. Its largest new stake was Atkore: 172,729 shares worth $23.3M. The largest sale was Medpace, an estimated $43.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2024 buy was Atkore: 172,729 shares worth $23.3M.
  • Boston Trust Walden added most to NVIDIA in Q2 2024, an estimated $46.3M increase.
  • Boston Trust Walden's biggest Q2 2024 reduction was Medpace, cutting an estimated $43.2M.
  • Boston Trust Walden fully exited Callon Petroleum Company in Q2 2024, selling an estimated $35.4M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $13.5B portfolio in Q2 2024.
  • Boston Trust Walden opened 13 new positions and closed 7 in Q2 2024.
  • Boston Trust Walden's portfolio value fell 3.8% quarter-over-quarter to $13.5B.

Based on Boston Trust Walden's 13F filing for Q2 2024, filed 19 Jul 2024.